Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00625248 · ClinicalTrials.gov registry record

Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy

A clinical trial, sponsored by Pain Management Center of Paducah.

Completed
Registry status
12,000
Enrollment target

NCT00625248: Completed study, sponsored by Pain Management Center of Paducah.

NCT00625248 is a clinical trial that has completed, run by Pain Management Center of Paducah. The registered enrollment target is 12,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00625248 has completed, sponsored by Pain Management Center of Paducah.

COMPLETED
Registry status
12,000 participants
Enrollment target

Study Summary

This study will evaluate bleeding risk and differences in outcomes in patients receiving and not receiving anticoagulant or antiplatelet therapy

Interventions

  • DRUG Antithrombotics

Trial Details

FieldValue
Enrollment Target 12,000 participants
Start Date 2008-02
Est. Completion 2010-01
Pain Management Center of Paducah

11 total trials

What the finished NCT00625248 record still lists

NCT00625248 is an observational study that tracks outcomes without assigning an intervention. Its 12,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Antithrombotics is the first listed.

NCT00625248 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00625248 about?

NCT00625248 is a clinical study titled "Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy". This study will evaluate bleeding risk and differences in outcomes in patients receiving and not receiving anticoagulant or antiplatelet therapy

What is the current status of trial NCT00625248?

This trial is currently completed. The enrollment target is 12,000 participants. The study started on 2008-02. Estimated completion is 2010-01.

What interventions are being tested in trial NCT00625248?

The interventions under investigation include: Antithrombotics (DRUG).

Who is sponsoring clinical trial NCT00625248?

This trial is sponsored by Pain Management Center of Paducah, which has 11 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01772771 · 12,000 participants

    Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

  • NCT04937868 · 12,000 participants

    Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients

  • NCT06059963 · 12,000 participants

    A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation

  • NCT06273618 · 12,000 participants · NA

    iLookOut Micro-learning to Improve Knowledge Retention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00625248, the US trial registry maintained by the National Library of Medicine. NCT00625248 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.